glutamine→Glutamine→Glutamine→pyruvate kinase

• 17709266(glutamine): Frequent intravenous pulses of growth hormone together with alanylglutamine supplementation in prolonged critical illness after multiple trauma: effects on glucose control, plasma IGF-I and glutamine.

  We also ask whether it is possible to control glycemia during such a treatment and how alanylglutamine (AG) supplementation influences plasma glutamine concentration.

• 17260533(Glutamine): [Glutamine use for parenteral nutrition in the critically ill patient: effects on morbimortality].

  To determine the relationship between adding glutamine dipeptides to parenteral nutrition (PN) and morbimortality in the critically ill patient.

• 16077744(Glutamine): Glutamine-enriched total parenteral nutrition in patients with inflammatory bowel disease.

  Studies in animal models of inflammatory bowel disease (IBD) suggest that supplementation of total parenteral nutrition with glutamine (gln) , a conditionally essential amino acid in catabolic conditions , increases gln plasma concentrations , reduces intestinal damage , improves nitrogen balance and may improve the course of the disease.

• 17577247(pyruvate kinase): Fecal M2-pyruvate kinase (M2-PK): a novel marker of intestinal inflammation.

  Surrogate markers of bowel inflammation are increasingly being recognized as important , not only as markers of disease activity in inflammatory bowel disease (IBD) but also to differentiate irritable bowel syndrome (IBS) from IBD.